Skip to main content

MedAvail Ranked in the Top 500 Fastest-Growing Companies in North America

PHOENIX, Nov. 17, 2022 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced that it ranked for the first time on the Deloitte Technology Fast 500™, an award aimed at recognizing innovative technology companies that redefine the cutting edge.

The award recognized MedAvail’s mission to transform the retail pharmacy industry by offering turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform – its MedCenter. Technology Fast 500 awardees are selected based on the percentage revenue growth from 2018 to 2021. MedAvail reported total revenue of $22.1 million in 2021, representing 374% growth since 2018.

“We are incredibly honored to have been distinguished among the top 500 fastest-growing innovative technology companies by an award that demonstrates our strong growth over the last few years. We are also excited to see our momentum continue in 2022, as we expand our retail pharmacy footprint and broaden our technology pipeline,” said Mark Doerr, chief executive officer of MedAvail. “We see a significant opportunity ahead for MedAvail as our team continues with strong execution across strategic initiatives and focus on improving patient medication access and adherence with our differentiated technology solution.”

About the 2022 Deloitte Technology Fast 500™

Now in its 28th year, the Deloitte Technology Fast 500 honors the most innovative, fastest-growing public and private companies all over North America. The awards program was created to recognize the passion and dedication it takes to be a disruptor across different industries, including the technology and life sciences sectors. The rankings are compiled based on submitted applications and public company database research, with winners selected based on their percentage fiscal-year revenue growth over a three-year period.

About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

Contacts:

Investor Relations
Ji-Yon Yi
Gilmartin Group
ir@medavail.com
SOURCE MedAvail Holdings, Inc.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.